Chau Q. Khuong
Chau Q. Khuong has been a member of our Board of Directors since 2020. Mr. Khuong is a biotech entrepreneur and venture capital investor. From 2003 until 2021, he worked at OrbiMed Advisors, a global healthcare-dedicated investment firm, where he was a Partner and member of the investment committee for the OrbiMed venture capital funds. Over the past two decades, he has been an active lead investor in innovative drug development and medical device enterprises across all stages and therapeutic areas including oncology, infectious diseases, ophthalmology, gene therapy and gene editing. Mr. Khuong currently serves or has served in a Board of Directors capacity of numerous public and private companies, including Arius Research (acquired by Roche), BELLUS Health, Durata (acquired by Actavis), Fusion Pharma, Glaukos Medical, Intellia, Intercept, Inspire Medical Systems, NextCure, Otonomy, Pieris, Rempex and ReViral. He holds a B.S. in molecular, cellular and developmental biology with a concentration in biotechnology and an M.P.H. with a concentration in infectious diseases, both from Yale University.